Heze Pharmaceutical
Latest round
- Series A
Last raised
- Aug 2016
Total raised
- Undisclosed
Investors
- 3
About Heze Pharmaceutical
Established in 2006 and based in Hangzhou, China, Heze Pharmaceutical is a pharmaceutical enterprise engaged in drug certification and conversion. It has partnerships with Huadong Medicine, Minsheng Pharma, Yongning Pharm, etc. Its subsidiaries include Hehui Pharmaceutical, Kunyuan Pharmaceutical, Yiyuan Pharmaceutical, etc. In 2021, it jointly established Hangzhou Heze Yuanzhi Chinese Medicine Technology with Zhejiang University of Traditional Chinese Medicine. In 2022, it established a subsidiary in Zhongshan. The company has a series of MAH-licensed products, covering innovative drugs, improved new drugs, and difficult generic drugs. It also developed the peptide drug R&D platform, small molecule drug R&D platform, liquid formulation platform, solid formulation R&D platform, reverse engineering platform, and clinical trial service platform.
Who invested in Heze Pharmaceutical
3 investors across 1 round
See all investors in Heze Pharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 22, 2016
Amount
Undisclosed
Investors
Questions about Heze Pharmaceutical
Who invested in Heze Pharmaceutical?
Heze Pharmaceutical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Heze Pharmaceutical raised?
Heze Pharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Heze Pharmaceutical last raise money?
Heze Pharmaceutical's most recent round on record is a Series A, in Aug 2016.
What does Heze Pharmaceutical do?
Established in 2006 and based in Hangzhou, China, Heze Pharmaceutical is a pharmaceutical enterprise engaged in drug certification and conversion.
Where is Heze Pharmaceutical headquartered?
Heze Pharmaceutical is headquartered in Hangzhou, China.
Which VCs invest in companies like Heze Pharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Heze Pharmaceutical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Heze Pharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.